New clinical data demonstrate excellent lesion durability with PulseSelect™ Pulsed Field Ablation System in real-world setting as approvals and adoption expand globally
Medtronic(MDT) Prnewswire·2024-09-28 07:00APHRS: New data confirm robust long-term durability and highly efficient procedure performed without fluoroscopySuccessful launch in Japan follows recent reimbursement approval Approvals across APAC including China and Australia broaden reach for patientsGALWAY, Ireland and SYDNEY, Sept. 27, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the presentation of clinical study results demonstrating a high rate of durable lesion formation for the PulseSe ...